CN1857636A - Chinese medicine capsule for treating protrusion of intervertebral disc and hyperosteogeny - Google Patents
Chinese medicine capsule for treating protrusion of intervertebral disc and hyperosteogeny Download PDFInfo
- Publication number
- CN1857636A CN1857636A CNA2006100433821A CN200610043382A CN1857636A CN 1857636 A CN1857636 A CN 1857636A CN A2006100433821 A CNA2006100433821 A CN A2006100433821A CN 200610043382 A CN200610043382 A CN 200610043382A CN 1857636 A CN1857636 A CN 1857636A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- intervertebral disc
- rhizoma
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a kind of Chinese medicine, named as Tongjing capsule, for treating protrusion of lumbar intervertebral disc and hyperosteogeny. The Chinese medicine is prepared with notopterygium, pubescent angelica root, clematis root, acanthopanax bark, kudzu vine root and other 12 kinds of Chinese medicinal materials. The medicine of the present invention is combined with the application of pelvic traction and hand restitution so as to reach high treating effect.
Description
Technical field
The present invention relates to a kind of is the pharmaceutical composition of raw material with the Chinese herbal medicine, specifically relates to a kind of Chinese medicinal capsule for the treatment of intervertebral disk hernia and bone matrix hyperplasia.
Background technology
Hyperosteogeny, intervertebral disc prolapse are a kind of commonly encountered diseases, frequently-occurring diseases that has a strong impact on work capacity, and in China the trend that increases are year by year arranged.The arthromyodynia category of the primary disease ownership traditional Chinese medical science.Chinese medicine thinks, the wind-cold damp pathogen invasion and attack, and acute and chronic trauma causes meridians impatency, QI-blood circulation smooth and cause a disease, so forefathers have " numbness person closes also ", the saying of " bitterly then obstructed, general rule is not bitterly ".The primary disease primary symptom is a lumbago and skelalgia, and it causes the machine-processed more complicated of lumbago and skelalgia, but mainly is mechanical pressure and two aspects of chemical stimulation.Mechanical pressure occurs formerly, after chemical stimulation occurs in.Aseptic inflammations such as the compressing of proliferation stimulates can cause nerve root hyperemia, ooze out, edema, degeneration, adhesion are secreted multiple algogenic substances such as Kallidin I then.Present treatment for primary disease, except that operation, major part is carried out expectant treatment, wherein pelvic traction and manual reduction are the most frequently used basic skills, though said method can alleviate mechanical pressure effectively, but it can not eliminate chemical stimulation effectively, remove the swelling and the congestion pain in partial wind-cold damp pathogen and affected part, and the course of treatment is longer.Existing oral drugs, Western medicine such as chlorzoxazone, ibuprofen, indometacin etc. mostly to unsting, can not effect a radical cure this disease, and patient is easy to generate drug dependence, take toxic side effect for a long time.And Chinese patent medicine such as bony spur tablet, SHENJIN DAN etc., though have no side effect, therapeutic effect is very unobvious." Chinese medicine composition of treatment intervertebral disc bone matrix hyperplasia " of external Chinese medicine such as patent No. ZL03142018.4 and " a kind of plaster for the treatment of intervertebral disc prolapse " of patent No. CN200310105386.4 etc., though effect is better, curative effect is long, the medication inconvenience.
Summary of the invention
Purpose of the present invention is exactly that a kind of oral Chinese medicine-capsule that stimulates the menstrual flow that is used with pelvic traction and manual reduction traction to treat will be provided, thereby can more effective, more promptly treat intervertebral disc prolapse and bone matrix hyperplasia.
For achieving the above object, the present invention's Chinese medicine-capsular characteristics of stimulating the menstrual flow for the treatment of intervertebral disc prolapse and bone matrix hyperplasia raw material of being to make this pharmaceutically active ingredient is formed and weight proportion is: Rhizoma Et Radix Notopterygii 1-2 part, Radix Angelicae Pubescentis 1-2 part, Radix Clematidis 2-3 part, Cortex Acanthopancis 2-3 part, Radix Puerariae 2-3 part, Radix Aconiti 2-3 part, Sanguis Draxonis 1-2 part, Olibanum 1-2 part, Myrrha 1-2 part, Flos Carthami 2-3 part, Rhizoma Drynariae 2-3 part, charred Cortex Eucommiae 2-3 part, Agkistrodon 2-3 part, Pheretima 1-2 part, Eupolyphaga Seu Steleophaga 1-2 part, Scorpio 1-2 part, Scolopendra 1-2 part.
The raw material optimum weight proportioning of making this pharmaceutically active ingredient is: 1 part of Rhizoma Et Radix Notopterygii, 1 part of Radix Angelicae Pubescentis, 2 parts of Radix Clematidis, 2 parts of Cortex Acanthopanciss, 2 parts of Radix Puerariaes, 2 parts of Radix Aconitis, 1.5 parts of Sanguis Draxonis, 1.5 parts of Olibanums, 1.5 parts of Myrrhas, 2 parts on Flos Carthami, 2 parts of Rhizoma Drynariae, 2 parts of charred Cortex Eucommiaes, 2 parts of Agkistrodons, 2 parts of Pheretimas, 2 parts of Eupolyphaga Seu Steleophagas, 1 part of Scorpio, 1 part of Scolopendra.
Chinese medicine-capsular the preparation method of stimulating the menstrual flow that the present invention treats intervertebral disc prolapse and bone matrix hyperplasia is: take by weighing the raw material of Chinese medicine of respectively distinguishing the flavor of by weight ratio, 120 mesh sieves are dried, pulverized to mix homogeneously, ozone sterilization 20 minutes, medicated powder incapsulated get final product every powder charge 0.45 gram.
The medicine of the present invention capsule that stimulates the menstrual flow is once taken 4, and twice, 30 day on the one is a course of treatment, and it is better to make the guiding drug effect with warm yellow wine.Capsule of the present invention has dispelling cold by warming the meridian, dispels damp, the effect of activating blood circulation to dissipate blood stasis, promotion local blood circulation, is used for treatment intervertebral disc prolapse and bone matrix hyperplasia, lays particular emphasis on and removes its chemical stimulation, promotes the metabolism of algogenic substance to get rid of.Through clinical verification for many years, medicine of the present invention combines application with pelvic traction and manual reduction traction to treat, can obtain better, curative effect more efficiently, and its cure rate can reach 60%, accounts for 80% more than the produce effects.Medicine of the present invention is pure Chinese medicinal preparation, and is without any side effects, and taking convenience is not taken for a long time and can be produced drug dependence, and raw material is easy to get, and drug cost is low, has alleviated the financial burden of patient treatment.
The specific embodiment
Embodiment one:
Making this invention medicine-capsule raw materials of effective components of stimulating the menstrual flow composition and weight proportion thereof is: 1 part of Rhizoma Et Radix Notopterygii, 2 parts of Radix Angelicae Pubescentiss, 2 parts of Radix Clematidis, 3 parts of Cortex Acanthopanciss, 2 parts of Radix Puerariaes, 3 parts of Radix Aconitis, 1 part of Sanguis Draxonis, 2 parts of Olibanums, 1 part of Myrrha, 3 parts on Flos Carthami, 2 parts of Rhizoma Drynariae, 3 parts of charred Cortex Eucommiaes, 2 parts of Agkistrodons, 2 parts of Pheretimas, 1 part of Eupolyphaga Seu Steleophaga, 2 parts of Scorpios, 1 part of Scolopendra.
Embodiment two:
Making this invention medicine-capsule raw materials of effective components of stimulating the menstrual flow composition and weight proportion thereof is: 2 parts of Rhizoma Et Radix Notopterygiis, 1 part of Radix Angelicae Pubescentis, 3 parts of Radix Clematidis, 2 parts of Cortex Acanthopanciss, 3 parts of Radix Puerariaes, 2 parts of Radix Aconitis, 2 parts of Sanguis Draxonis, 1 part of Olibanum, 2 parts of Myrrhas, 2 parts on Flos Carthami, 3 parts of Rhizoma Drynariae, 2 parts of charred Cortex Eucommiaes, 3 parts of Agkistrodons, 1 part of Pheretima, 2 parts of Eupolyphaga Seu Steleophagas, 1 part of Scorpio, 2 parts of Scolopendras.
Embodiment three
Making this invention medicine-capsule raw materials of effective components of stimulating the menstrual flow composition and weight proportion thereof is: 1 part of Rhizoma Et Radix Notopterygii, 1 part of Radix Angelicae Pubescentis, 2 parts of Radix Clematidis, 2 parts of Cortex Acanthopanciss, 2 parts of Radix Puerariaes, 2 parts of Radix Aconitis, 1.5 parts of Sanguis Draxonis, 1.5 parts of Olibanums, 1.5 parts of Myrrhas, 2 parts on Flos Carthami, 2 parts of Rhizoma Drynariae, 2 parts of charred Cortex Eucommiaes, 2 parts of Agkistrodons, 2 parts of Pheretimas, 2 parts of Eupolyphaga Seu Steleophagas, 1 part of Scorpio, 1 part of Scolopendra.
Embodiment three is a most preferred embodiment.The preparation method of embodiment as previously described.
Claims (2)
1, a kind of Chinese medicinal capsule for the treatment of intervertebral disc prolapse and bone matrix hyperplasia is characterized in that raw material composition and the weight proportion thereof of making this pharmaceutically active ingredient are: Rhizoma Et Radix Notopterygii 1-2 part, Radix Angelicae Pubescentis 1-2 part, Radix Clematidis 2-3 part, Cortex Acanthopancis 2-3 part, Radix Puerariae 2-3 part, Radix Aconiti 2-3 part, Sanguis Draxonis 1-2 part, Olibanum 1-2 part, Myrrha 1-2 part, Flos Carthami 2-3 part, Rhizoma Drynariae 2-3 part, charred Cortex Eucommiae 2-3 part, Agkistrodon 2-3 part, Pheretima 1-2 part, Eupolyphaga Seu Steleophaga 1-2 part, Scorpio 1-2 part, Scolopendra 1-2 part.
2, the Chinese medicinal capsule of treatment intervertebral disc prolapse according to claim 1 and bone matrix hyperplasia is characterized in that raw material composition and the weight proportion thereof of making this pharmaceutically active ingredient are: 1 part of Rhizoma Et Radix Notopterygii, 1 part of Radix Angelicae Pubescentis, 2 parts of Radix Clematidis, 2 parts of Cortex Acanthopanciss, 2 parts of Radix Puerariaes, 2 parts of Radix Aconitis, 1.5 parts of Sanguis Draxonis, 1.5 parts of Olibanums, 1.5 parts of Myrrhas, 2 parts on Flos Carthami, 2 parts of Rhizoma Drynariae, 2 parts of charred Cortex Eucommiaes, 2 parts of Agkistrodons, 2 parts of Pheretimas, 2 parts of Eupolyphaga Seu Steleophagas, 1 part of Scorpio, 1 part of Scolopendra.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100433821A CN100396316C (en) | 2006-03-21 | 2006-03-21 | Chinese medicine capsule for treating protrusion of intervertebral disc and hyperosteogeny |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100433821A CN100396316C (en) | 2006-03-21 | 2006-03-21 | Chinese medicine capsule for treating protrusion of intervertebral disc and hyperosteogeny |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1857636A true CN1857636A (en) | 2006-11-08 |
| CN100396316C CN100396316C (en) | 2008-06-25 |
Family
ID=37296624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100433821A Expired - Fee Related CN100396316C (en) | 2006-03-21 | 2006-03-21 | Chinese medicine capsule for treating protrusion of intervertebral disc and hyperosteogeny |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100396316C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102600327A (en) * | 2012-03-06 | 2012-07-25 | 爨新德 | Ostealgia treating capsule |
| CN105477599A (en) * | 2015-12-17 | 2016-04-13 | 丁雪莲 | Ointment for treating hyperostosis |
| CN106692572A (en) * | 2017-03-03 | 2017-05-24 | 贵州都匀市剑江药业有限公司 | Traditional Chinese medicine composition for treating osteoproliferation and preparation method thereof |
| CN114668822A (en) * | 2022-04-25 | 2022-06-28 | 王培业 | Traditional Chinese medicine compound for treating intervertebral disc protrusion |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1066043C (en) * | 1993-10-29 | 2001-05-23 | 高崇才 | Gucixiao capable of removing spur and preparation technology thereof |
| CN1136888C (en) * | 2001-05-09 | 2004-02-04 | 陈志友 | Medicine for treating hyperosteogeny and protrusion of lumber intervertebral disc and its preparation |
-
2006
- 2006-03-21 CN CNB2006100433821A patent/CN100396316C/en not_active Expired - Fee Related
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102600327A (en) * | 2012-03-06 | 2012-07-25 | 爨新德 | Ostealgia treating capsule |
| CN105477599A (en) * | 2015-12-17 | 2016-04-13 | 丁雪莲 | Ointment for treating hyperostosis |
| CN106692572A (en) * | 2017-03-03 | 2017-05-24 | 贵州都匀市剑江药业有限公司 | Traditional Chinese medicine composition for treating osteoproliferation and preparation method thereof |
| CN114668822A (en) * | 2022-04-25 | 2022-06-28 | 王培业 | Traditional Chinese medicine compound for treating intervertebral disc protrusion |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100396316C (en) | 2008-06-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1742994A (en) | Chinese foot-soaking powder | |
| CN103446264A (en) | Physical therapy liquid for treating neck-shoulder and lumbocrural pains and preparation method thereof | |
| CN102309723A (en) | Traditional Chinese medicine composition for treating arthralgia and preparation method of ointment thereof | |
| CN100396316C (en) | Chinese medicine capsule for treating protrusion of intervertebral disc and hyperosteogeny | |
| CN101850092A (en) | Medicament for treating trauma and preparation method thereof | |
| CN1069527C (en) | Medicine for hyperosteogeny and wind-cold syndrome | |
| CN102526482A (en) | Traditional Chinese medicine preparation for treating lumbar disc herniation | |
| CN101322775B (en) | Chinese medicine for treating psoriasis | |
| CN1281228C (en) | Medicine for hyperplasia of mammary glands and its preparation | |
| CN101214365A (en) | Chinese medicine composing prescription for treating mastoproliferation | |
| CN102038930A (en) | Medicament for treating protrusion of lumbar vertebral disc | |
| CN101057957A (en) | External applied traditional Chinese medicine lotion for treating osteoproliferation and bony spur | |
| CN100475247C (en) | External application medicine for treating vertebrae lumbales hyperosteogeny | |
| CN1843492A (en) | Traditional Chinese medicine preparation for treating mammary gland hyperplasia | |
| CN1958064A (en) | Chinese traditional medicine for external application of treating rheumatism like disease, preparation method and usage | |
| CN1127664A (en) | External use medicinal bag for treating acute and chronic gastritis and cholecystitis, and preparing method thereof | |
| CN102343081A (en) | Moxibustion tool of pure Chinese medicinal preparation for treating bone aching and pure Chinese medicinal preparation for treating bone aching | |
| CN102727639A (en) | External-use medicine for treating venereal disease | |
| CN101297937B (en) | Chinese patent medicine formulation for treating cervical vertebra disease and preparation thereof | |
| CN102526544B (en) | Oral powder Chinese medicine formula for treating lumbar disc herniation and osteoproliferation | |
| CN101185697B (en) | Ointment medicine for treating anal fissure | |
| CN101361889A (en) | Traditional Chinese medicine capsule for treating psoriasis | |
| CN1823960A (en) | Traditional Chinese medicine for treating hemorrhoid | |
| CN105833074A (en) | Traditional Chinese medicine composition for treating oral ulcer | |
| CN1065137C (en) | Liniment made of traditional Chinese medicine for treating pharyngitis, and prepn. method therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080625 Termination date: 20120321 |